Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
基本信息
- 批准号:10248819
- 负责人:
- 金额:$ 7.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-13 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAcute Lung InjuryAcute Renal Failure with Renal Papillary NecrosisAddressAdmission activityAreaArkansasAwardBasic ScienceBlood VesselsCardiopulmonaryCardiovascular DiseasesCaringCatchment AreaChildChild DevelopmentChild HealthChildhoodChildhood InjuryClinicalClinical ResearchClinical SciencesClinical TrialsClinical and Translational Science AwardsColoradoComplement ActivationContractsCritical CareCritical IllnessCritically ill childrenDataData Coordinating CenterDevelopmentDisciplineDiseaseEnrollmentEnsureEvaluationFacultyFamilyFunctional disorderFundingGeographyGoalsGood Clinical PracticeImmune responseInstitutesInstitutionInvestigationKnowledgeLaboratoriesLeadershipLinkLocationLongitudinal StudiesLower Respiratory Tract InfectionLungLung diseasesMedicineMentorsMetadataMissionMississippiMolecularMultiple Organ FailureNational Heart, Lung, and Blood InstituteOrganOutcomeOutpatientsParticipantPathogenesisPatientsPediatric Acute Lung InjuryPediatric Acute Respiratory Distress SyndromePediatric HospitalsPerformancePhysiciansPopulationPopulation HeterogeneityPrincipal InvestigatorProceduresProcessProgram DevelopmentProtocols documentationPublicationsRecording of previous eventsRehabilitation therapyResearchResearch DesignResearch InstituteResearch PersonnelResearch PriorityResearch TrainingResourcesRespiratory FailureRoleRuralSECTM1 geneScientistSepsisSeriesSiteTalentsTherapeuticTrainingTraining ProgramsTranslational ResearchTranslationsTraumatic Brain InjuryUnited States National Institutes of HealthUniversitiesVascular DiseasesWorkalveolar epitheliumcarbohydrate metabolismcareer developmentclinical research sitecohorteffective therapyexpectationexperiencefollow-upimmunoregulationimproved outcomeinnovationmedically underservedmeetingsmembermultidisciplinarynext generationoutreach programparticipant enrollmentpathogenpatient populationpediatric departmentprogramsracial and ethnicrespiratory microbiomesevere injurysocioeconomicssuccesstranslational clinical trialunderserved community
项目摘要
ABSTRACT – University of Colorado Denver
With our participation in this iteration of the Collaborative Pediatric Critical Care Research Network (CPCCRN),
we contributed to a series of discoveries that enhanced our understanding of disease processes and resulted in
a multitude of potentially effective treatments for critically ill and injured children that require definitive evaluation
in clinical trials. There continues to be tremendous need for a collaborative research network in pediatric critical
care to facilitate the swift and effective translation of scientific and technologic discoveries into clinical advances.
Access to appropriate patients and expertise in the execution of clinical trials must be linked to scientists and
laboratories working within and across disciplines at the cutting edge of scientific advancement. At the University
of Colorado Denver (UCD) and Children’s Hospital Colorado (CHCO), we have a long history of successful
collaborative basic, translational, and clinical science programs focused on pediatric critical illness and injury.
We will provide several unique areas of strength to the CPCCRN, including: 1) a distinctive multidisciplinary team
of collaborative researchers with specific expertise in mechanistic investigations of cardiovascular and
pulmonary diseases, 2) a proven and successful track record as a clinical site in CPCCRN, 3) expertise with
pediatric clinical trials execution, including innovative programs to enhance positive research culture among
clinical staff and participation among patients and families, 4) a 7-state catchment area with high volumes of
critically ill and injured children, 5) an in-house rehabilitation program and extensive outpatient outreach program
capable of providing follow-up care to nearly all our critically ill patients, and 6) a dynamic partnership with the
Children’s Hospital Colorado Research Institute and Colorado Clinical Translational Science Institute to provide
extensive research resources. Our ancillary site, Arkansas Children’s Hospital (ACH) provides 1) experience
with pediatric clinical trials execution, including previous successful membership in CPCCRN 2) provision of care
to nearly all of the critically ill children from the State of Arkansas and a 4-state catchment area, 3) representation
of an Institutional Development Award (IDeA) state (historically received low levels of NIH support) and involving
their unique populations (rural, Marshallese, and medically underserved communities) in the NIH mission, and
4) a rich partnership with the ACH Research Institute and University of Arkansas Clinical Translational Science
Award to provide comprehensive research resources. Utilizing these assets, we will augment the contributions
of CPCCRN to the care of critically ill children through rigorous clinical trial execution, innovative translational
and clinical trial proposals, participation in CPCCRN leadership committees, and training the next generation of
pediatric critical care researchers. The proposed trial of “Personalized Immunomodulation in Sepsis induced
Multiple Organ Dysfunction Syndrome” is an incredibly innovative approach that moves beyond a “one therapy
for all” paradigm to an individualized therapeutic approach that will dramatically improve outcomes for children
with sepsis. We are enthusiastic and committed to participate in this project with the new 24-site CPCCRN.
摘要 - 科罗拉多大学丹佛分校
我们参与了协作小儿重症监护研究网络(CPCCRN)的这种迭代,
我们为一系列发现做出了贡献,这些发现增强了我们对疾病过程的理解,并导致了
需要确定评估的重症儿童和受伤儿童的多种潜在有效治疗
在临床试验中。在小儿批判性的协作研究网络中仍然非常需要
注意将科学和技术发现迅速有效地转化为临床进展。
获得适当的患者和执行临床试验的专业知识必须与科学家有关
在科学进步的最前沿内部和跨学科工作的实验室。在大学
科罗拉多州丹佛(UCD)和科罗拉多州儿童医院(CHCO)的雕像,我们有悠久的成功历史
协作基础,翻译和临床科学计划的重点是小儿重症疾病和伤害。
我们将为CPCCRN提供几个独特的优势领域,包括:1)独特的多学科团队
在心血管和
肺部疾病,2)在CPCCRN中作为临床部位的经过验证的成功记录,3)专业知识
小儿临床试验执行,包括增强积极研究文化的创新计划
患者和家庭之间的临床人员和参与,4)一个7状态的集水区
重病和受伤的孩子,5)内部康复计划和广泛的门诊外展计划
能够为几乎所有重症患者提供后续护理,6)与
儿童医院科罗拉多州研究所和科罗拉多州临床转化科学研究所提供
广泛的研究资源。我们的辅助网站,阿肯色州儿童医院(ACH)提供1)经验
通过小儿临床试验执行,包括以前成功的CPCCRN会员资格2)提供护理
几乎所有来自阿肯色州和四州集水区的重症儿童
机构发展奖(IDEA)国家(历史上获得低水平的NIH支持),并涉及
他们在NIH任务中的独特人口(农村,马歇尔和医学服务不足的社区),以及
4)与ACH研究所和阿肯色大学临床转化科学的丰富合作伙伴关系
奖励提供全面的研究资源。利用这些资产,我们将增加捐款
CPCCRN通过严格的临床试验执行,创新的翻译来照顾重症儿童
以及临床试验建议,参加CPCCRN领导委员会以及培训下一代
小儿重症监护研究人员。拟议的“败血症中个性化免疫调节的试验
多器官功能障碍综合征”是一种令人难以置信的创新方法,它超越了“一种疗法
对于所有的“范式”范式,将大大改善儿童的预后
与败血症。我们很热情,并致力于与新的24个站点CPCCRN一起参加该项目。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER M MOURANI其他文献
PETER M MOURANI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER M MOURANI', 18)}}的其他基金
Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
- 批准号:
10468850 - 财政年份:2021
- 资助金额:
$ 7.24万 - 项目类别:
Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
- 批准号:
10670251 - 财政年份:2021
- 资助金额:
$ 7.24万 - 项目类别:
The Microbiome, Virome and Host Responses Preceding Ventilator-Associated Pneumon
呼吸机相关肺炎发生前的微生物组、病毒组和宿主反应
- 批准号:
8764528 - 财政年份:2014
- 资助金额:
$ 7.24万 - 项目类别:
Collaborative Network Study of Airway Microbiome and Host Responses in Pediatric Respiratory Failure
儿科呼吸衰竭气道微生物组和宿主反应的协作网络研究
- 批准号:
8991004 - 财政年份:2014
- 资助金额:
$ 7.24万 - 项目类别:
The Microbiome, Virome and Host Responses Preceding Ventilator-Associated Pneumon
呼吸机相关肺炎发生前的微生物组、病毒组和宿主反应
- 批准号:
9290958 - 财政年份:2014
- 资助金额:
$ 7.24万 - 项目类别:
The Microbiome, Virome and Host Responses Preceding Ventilator-Associated Pneumon
呼吸机相关肺炎发生前的微生物组、病毒组和宿主反应
- 批准号:
9069970 - 财政年份:2014
- 资助金额:
$ 7.24万 - 项目类别:
PILOT STUDY OF IMPAIRED ANGIOGENIC SIGNALING IN BRONCHOPULMONARY DYSPLASIA
支气管肺发育不良血管生成信号传导受损的试点研究
- 批准号:
7605138 - 财政年份:2007
- 资助金额:
$ 7.24万 - 项目类别:
PILOT STUDY OF VEGF AND ENOS POLYMORPHISMS IN NEONATES
新生儿 VEGF 和 ENOS 多态性的初步研究
- 批准号:
7202444 - 财政年份:2005
- 资助金额:
$ 7.24万 - 项目类别:
Pathogenetic Mechanisms of Brochopulmonary Dysplasia
支气管肺发育不良的发病机制
- 批准号:
7283095 - 财政年份:2005
- 资助金额:
$ 7.24万 - 项目类别:
Pathogenetic Mechanisms of Brochopulmonary Dysplasia
支气管肺发育不良的发病机制
- 批准号:
7493449 - 财政年份:2005
- 资助金额:
$ 7.24万 - 项目类别:
相似国自然基金
DUSP2介导自噬调控气管上皮细胞炎症在急性肺损伤中的机制研究
- 批准号:82360379
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
基于巨噬细胞炎性小体活化探究木犀草素治疗急性肺损伤的新机制
- 批准号:82374186
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
CDK4/6抑制下调衰老中性粒细胞促炎效应改善急性肺损伤的机制和干预研究
- 批准号:82302445
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于肺间充质干细胞源外泌体lncRNA表达谱差异探讨益气活血解毒法改善脓毒症急性肺损伤的机制
- 批准号:82374400
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
相似海外基金
Resident Memory T cells in Chronic Kidney Disease
慢性肾脏病中的常驻记忆 T 细胞
- 批准号:
10676628 - 财政年份:2023
- 资助金额:
$ 7.24万 - 项目类别:
The role of amphiregulin in mediating radiation cystitis in cancer survivors
双调蛋白在介导癌症幸存者放射性膀胱炎中的作用
- 批准号:
10636699 - 财政年份:2023
- 资助金额:
$ 7.24万 - 项目类别:
SCH: Graph-based Spatial Transcriptomics Computational Methods in Kidney Diseases
SCH:肾脏疾病中基于图的空间转录组学计算方法
- 批准号:
10816929 - 财政年份:2023
- 资助金额:
$ 7.24万 - 项目类别:
Spatiotemporal regulation of polyploidy in zebrafish cardiac tissue regeneration
斑马鱼心脏组织再生中多倍体的时空调控
- 批准号:
10736051 - 财政年份:2023
- 资助金额:
$ 7.24万 - 项目类别:
PHEnylephrine versus NOrepinephrine in Major NONcardiac surgery (PHENOMeNON): Foundational Studies for a Pragmatic Randomized Clinical Trial.
PHEnylephrine 与 NOrepinephrine 在主要非心脏手术 (PHENOMeNON) 中的比较:实用随机临床试验的基础研究。
- 批准号:
10570637 - 财政年份:2023
- 资助金额:
$ 7.24万 - 项目类别: